Watch Demo

Australia Cardiovascular Drug Industry Outlook 2022 - 2026

See how Australia Cardiovascular Drug performed compared to key markets such as Germany, Italy and Canada.

Key Market Indicators

Sales of beta blocking medicines in Australia are expected to reach $130 million by 2026, growing just 0.8% year-on-year. Since 1995, the Australian market has grown 2.3% each year. In 2021, the country was the fourth biggest in the world, beaten by Canada, which recorded sales of $127 million. Italy, Canada and Australia took the top three spots in the rankings.

Marketing Banner

Australia Cardiovascular Drug Market Data and Forecasts

How much will Australia Cardiovascular Drug Market grow to 2026?

Forecast: Antiarrhythmic Medicine Sales in Australia
Forecast: Diuretic Medicine Sales in Australia
Forecast: Beta Blocking Medicine Sales in Australia
Forecast: Cardiac Glycosides Sales in Australia
Forecast: Diuretic Medicine Sales in Australia
More in Cardiovascular Drug Industry for 2028

Improve your Knowledge with the latest Indicators and Trends